American Medical Association

SHERPA: White

People

  1. Offit
    Offit
  2. O'Reilly
    O'Reilly
  3. Saltz
    Saltz
  4. Scher
    Scher
  5. Robson
    Robson
  6. Berger
    Berger
  7. Hudis
    Hudis
  8. Ladanyi
    Ladanyi
  9. Motzer
    Motzer
  10. Lee
    Lee

Groups

  1. Department of Medicine (233)
  2. Solid Tumor Oncology Division (233)
  3. Survivorship Research (77)
  4. Population Sciences Research Program (75)
  5. Gastrointestinal Oncology Service (59)
  6. Breast Medicine Service (54)
  7. GSK Faculty (52)
  8. Center for Pancreatic Cancer Research (48)
  9. Genitourinary Oncology Service (48)
  10. Epidemiology and Biostatistics (47)
Search Within
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (182)
  2. Correspondence (16)
  3. Review (14)
  4. Research Letter (10)
  5. Editorial (9)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Department of Medicine (233)
  2. Solid Tumor Oncology Division (233)
  3. Survivorship Research (77)
  4. Population Sciences Research Program (75)
  5. Gastrointestinal Oncology Service (59)
  6. Breast Medicine Service (54)

More Groups

People
  1. Kenneth Offit (22)
  2. Eileen O'Reilly (18)
  3. Leonard Saltz (17)
  4. Howard Scher (14)
  5. Mark Robson (13)
  6. Michael Berger (11)

More People

Years
  1. 2025 (7)
  2. 2024 (15)
  3. 2023 (15)
  4. 2022 (20)
  5. 2021 (16)
  6. 2020 (20)

More Years

Publications
  1. JAMA Oncology (146)
  2. JAMA - Journal of the American Medical Association (56)
  3. JAMA Surgery (7)
  4. JAMA Dermatology (5)
  5. JAMA Network Open (5)
  6. JAMA Ophthalmology (4)

More Publications

Results (233)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic ancestry-based differences in biomarker-based eligibility for precision oncology therapies
    Journal Article

    Arora, K.; Suehnholz, S. P.; Zhang, H.; Ostrovnaya, I.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Brannon, A. R.; Bandlamudi, C.; Ladanyi, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Intracranial outcomes of ipilimumab and nivolumab in melanoma brain metastases after progression on anti-PD-1 therapy
    Research Letter

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Chen, M. F.; Momtaz, P.; Shoushtari, A. N.; Panageas, K. S.; Postow, M. A.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Best practices for delivering neoadjuvant therapy in pancreatic ductal adenocarcinoma
    Journal Article

    Cloyd, J. M.; Sarna, A.; Arango, M. J.; Bates, S. E.; Bhutani, M. S.; Bloomston, M.; Chung, V.; Dotan, E.; Ferrone, C. R.; Gambino, P. F.; more...
    JAMA Surgery (2025)

    Fulltext@MSK | Save
  • Neoadjuvant exercise therapy in patients with prostate cancer - In reply
    Correspondence

    Jones, L. W.; Ehdaie, B.; Boutros, P. C.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • A values proposition for cancer care
    Editorial

    Rosa, W. E.; Epstein, A. S.; Nelson, J. E.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Survival among patients with ERBB2-positive metastatic breast cancer and central nervous system disease
    Journal Article

    Ferraro, E.; Reiner, A. S.; Bou Nassif, R.; Tosi, U.; Brown, S.; Zeller, S.; Dang, C. T.; Seidman, A. D.; Moss, N. S.
    JAMA Network Open (2025)

    Fulltext@MSK | Save
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Breast cancer susceptibility gene sequence variations and development of contralateral breast cancer
    Journal Article

    Reiner, A. S.; Watt, G. P.; Malone, K. E.; Lynch, C. F.; John, E. M.; Knight, J. A.; Woods, M.; Liang, X.; Tischkowitz, M.; Conti, D. V.; more...
    JAMA Network Open (2024)

    Fulltext@MSK | Save
  • Lynch syndrome and somatic mismatch repair variants in pancreas cancer
    Journal Article

    O'Connor, C. A.; Harrold, E.; Lin, D.; Walch, H.; Gazzo, A.; Ranganathan, M.; Kane, S.; Keane, F.; Schoenfeld, J.; Moss, D.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Rogaratinib plus atezolizumab in cisplatin-ineligible patients with FGFR RNA-overexpressing urothelial cancer: The FORT-2 phase 1b nonrandomized clinical trial
    Journal Article

    Sweis, R. F.; Gajate, P.; Morales-Barrera, R.; Lee, J. L.; Necchi, A.; De Braud, F.; Penel, N.; Grünwald, V.; Maruzzo, M.; Meran, J.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save